Termination of early pregnancy using flexible, low-dose mifepristone-misoprostol regimens

Contraception

Volumn 76, Issue 6, 2007, Pages 456-460

  Heikinheimo, Oskari ^a   Leminen, Riikka ^a   Suhonen, Satu ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Efficacy; Medical abortion; Outcome; Patient selection

Indexed keywords

MIFEPRISTONE; MISOPROSTOL;

ADULT; ARTICLE; CLINICAL TRIAL; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; FEMALE; FOLLOW UP; GESTATIONAL AGE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MATERNAL AGE; PARITY; PREGNANCY; PREGNANCY TERMINATION; RISK FACTOR; SMOKING; THERAPEUTIC ABORTION;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, THERAPEUTIC; ADMINISTRATION, INTRAVAGINAL; ADOLESCENT; ADULT; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MIFEPRISTONE; MISOPROSTOL; PREGNANCY; PREGNANCY TRIMESTER, FIRST; TREATMENT OUTCOME;

EID: 36549074151     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2007.08.012     Document Type: Article

References (16)

1. Webster D., Penney G., and Templeton A. A comparison of 600 and 200 mg mifepristone prior to second trimester abortion with the prostaglandin misoprostol. BJOG 103 (1996) 706-709
2. World Health Organization Task Force on Post-ovulatory Methods of Fertility Regulation. Termination of pregnancy with reduced doses of mifepristone. BMJ 307 (1993) 532-537
3. World Health Organization Task Force on Post-ovulatory Methods of Fertility Regulation. Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomized trial. BJOG 107 (2000) 524-530
4. El-Rafaey H., Rajasekar D., Abdalla M., Calder L., and Templeton A. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med 322 (1995) 983-987
5. Ashok P., Templeton A., Wagaarachi P., and Flett G. Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases. BJOG 109 (2002) 1281-1289
6. Bartley J., Tong S., Everington D., and Baird D. Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost. Contraception 62 (2000) 297-303
7. Bartley J., Brown A., Elton R., and Baird D. Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion of up to 63 days gestation. Hum Reprod 16 (2001) 2098-2102
8. Swahn M.L., and Bygdeman M. The effect of the antiprogestin RU486 on uterine contractility and sensitivity to prostaglandin and oxytocin. BJOG 95 (1988) 126-134
9. Schaff E., Fielding S., Westhoff C., et al. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion. JAMA 284 (2000) 1948-1953
10. Creinin M., Schreiber C., Bednarek P., et al., and Medical Abortion at the Same Time Study Trial Group. Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: a randomized controlled trial. Obstet Gynecol 109 (2007) 885-894
11. Guest J., Chien P., Thomson M., and Kosseim M. Randomized controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol. BJOG 114 (2007) 207-215
12. Suhonen S., Heikinheimo O., Tikka M., and Haukkamaa M. The learning curve is rapid in medical termination of pregnancy - first-year results from the Helsinki area. Contraception 67 (2003) 223-227
13. www.stakes.fi/FI/Tilastot/Aiheittain/Lisaantyminen/raskaudenkeskeytykset /index.htm [Accessed June 7, 2007].
14. Shannon C., Wiebe E., Jacot F., et al. Regimens of misoprostol with mifepristone for early medical abortion: a randomized study. BJOG 113 (2006) 621-628
15. www.controlled-trials.com/ISRCTN87811512/A35148 [Accessed May 6, 2007].
16. Spitz I., Bardin W., Benton L., and Robbins A. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 338 (1998) 1241-1247